Detailed answers about HARNESS THERAPEUTICS LIMITED, including incorporation, status, business activity, and accounts information.
When was HARNESS THERAPEUTICS LIMITED founded?
HARNESS THERAPEUTICS LIMITED was officially incorporated on 22 August 2018 and is registered under company number 11532498. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is HARNESS THERAPEUTICS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of HARNESS THERAPEUTICS LIMITED?
HARNESS THERAPEUTICS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does HARNESS THERAPEUTICS LIMITED do?
HARNESS THERAPEUTICS LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is HARNESS THERAPEUTICS LIMITED's registered address?
The registered office address of HARNESS THERAPEUTICS LIMITED is MINERVA BUILDING (B250), BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, UNITED KINGDOM, CB22 3AT. This is the official address filed with Companies House for legal and statutory correspondence.
Is HARNESS THERAPEUTICS LIMITED financially stable?
The most recent accounts for HARNESS THERAPEUTICS LIMITED were made up to 31 December 2024, filed as SMALL. Next accounts are due by 30 September 2026.
Has HARNESS THERAPEUTICS LIMITED changed its name?
Yes, HARNESS THERAPEUTICS LIMITED has had 1 previous name: TRANSINE THERAPEUTICS LIMITED (changed 22 January 2024).